• Home
  • Contact
  • Phone: (267) 971-7725
  • Join our Facebook Group
  • Subscribe to our RSS Feed
  • Search Site

Bioquark

  • BackgroundMission & Strategy
  • The OpportunityThe Health Care Gap
  • Our ProgramsBioquantines
    • BQ-A
    • BQ-A In-Vivo Studies
    • BQ-A Clinical Plans
    • Health, Wellness and Beauty Care
    • Articles / Shows / Press Releases / Publications
    • Future Bioquantine Programs
  • About UsOur History
    • Our Team
  • Contact UsGet in Touch

You are here: Bioquark / Bioquantine Programs

Bioquantine Programs

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth.  However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

The integration of a complex set of newer research disciplines, including inter-kingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome and virome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

Our strategy of tissue regulatory state modification represents a unique approach towards naturally communicating with, and affecting, various hierarchical control centers of the human “disease-ome”, and offers possibilities for the reversal and cure of a wide range of degenerative human conditions.

We refer to our combinatorial biologic candidates as the Bioquantines.

  • BQ-A
  • BQ-A In-Vivo Studies
  • BQ-A Clinical Plans
  • Health, Wellness and Beauty Care
  • Articles / Shows / Press Releases / Publications
  • Future Bioquantine Programs
Bioquark Inc. is a life sciences company, developing proprietary combinatorial biologics for the regeneration and repair of human organs and tissues.

BQ-A

BQ-A represents the first in a class of tissue regulatory state modifiers, which interact with the control apparatus of the genome to affect disease cure. (read more)

BQ-A In-Vivo Studies

BQ-A has been administered by several methods including subcutaneously, intraperitoneally, intratumorally, and topically. (read more)

BQ-A Clinical Plans

Bioquark is focusing on generating human clinical data in multiple therapeutic indications of unmet medical need. (read more)
© Copyright - Bioquark
  • scroll to top
  • Join our Facebook Group
  • Subscribe to our RSS Feed